Hepatology Flashcards
1
Q
Hep A
A
- infectious hepatitis
- endemic world-wide
- high incidence in low SE areas
- transmission routes
* *FECAL-ORAL
* *sexually
* *close personal contact
* *body fluids, including saliva
2
Q
Hep A Clinical Features
A
- 2-6 week incubation
- fatigue, nausea, vomiting, abdominal pain, anorexia, fever, jaundice, itching
- uneventful recovery
- long-lasting immunity
- HAV VACCINE available
3
Q
Hep B
A
- serum hepatitis
- affects 1/3 of population
- Outcomes
* *lifelong infection
* *cirrhosis
* *liver cancer
* *liver failure
* *fulminant hepatitis–>death
4
Q
Hep B Transmission Routes
A
- parenteral (IVDU and tattooing/piercing)
- unsafe sex
- perinatal
- survives in dried blood (1 week)
- easily transmissible in health care settings
- transmission declined after HBV VACCINE
5
Q
Clinical Features of Hep B
A
- carrier state (5-10%)
* *asymptomatic
* *can develop chronic liver disease - infection and recovery=IMMUNITY
- 2-6 month incubation
- acute mortality <2%
- most patients recover uneventfully
- Prodrome (1-2 weeks)
* *anorexia
* *malaise
* *nausea - 30% are asymptomatic
6
Q
HBsAg
A
- serological marker for Hep B
- acute infection–>20-120 days post-infection
- chronic infection–>13 weeks post-jaundice
7
Q
Anti-HBs
A
- serological marker for Hep B
- two possibilities
* *recovery and immunity
* *successful vaccination
8
Q
HBcAg
A
- serological marker for Hep B
2. current or recurrent infection
9
Q
Anti-HBc
A
- serological marker for Hep B
- with anti-HBs–>recovery and immunity
- without anti-HBs–>carrier/chronic hepatitis
10
Q
HBeAg
A
- serological marker for Hep B
2. ongoing infectivity
11
Q
Anti-HBe
A
- serological marker for Hep B
- inactive state
- complete recovery if HBeAg absent
12
Q
General Management for Hep B
A
- HBV vaccination
* *NO NEED for testing
* *NO NEED for booster dose - infection control
13
Q
Dental Aspects for Hep B
A
- all dental professionals should be vaccinated
- HBV in saliva from gingival exudate
* *LOW transmission risk - needlestick injury
* *HIGH transmission risk
* *post-exposure prophy
14
Q
Hep C
A
1. non A/non B hepatitis 2 #2 cause of liver disease (#1 ETOH) 3. common in IVDUs 4. similar incubation to Hep B 5. often asymptomatic 6. elevated liver function tests 7. chronic liver disease (85%) 8. mortality (3%)
15
Q
General Management of Hep C
A
- serological confirmation of infection
- 50% spontaneous resolution
- NO vaccines
16
Q
Dental Aspects of Hep C
A
- transmission in health care clinics
- found in saliva
- transmitted by human bite
- hep c positive–>avoid exposure prone procedures
- associated with lichen planus??
17
Q
Drug-induced Hep
A
- alcohol
- NSAIDs
- antimicrobials
- herbs/nutritional supplements
- acetaminophen
- aspirin (children with viral infections)
* *REYE SYNDROME
18
Q
Cirrhosis
A
scarring of the liver
- inflammation
- necrosis
- fibrosis
- vascular derangement
- decreased function
- obstructed blood flow
19
Q
Clinical Features of Cirrhosis
A
- obstructed portal circulation
* *portal hypertension
* *esophageal varices
* *GI hemorrhage
* *heamtemesis
* *anemia - splenomegaly–>thrombocytopenia
- decreased clotting factors
20
Q
Symptoms of Cirrhosis
A
- encephalopathy
- jaundice
- spider naevi
- ascites peritonitis (retention of fluid)
- sialosis–>enlargement of salivary glands
- periontitis
- peptic ulcers
- finger clubbing
21
Q
General Management of Cirrhosis
A
- dietary alterations
- diuretics
- beta-blockers
- ligation/shunting
- liver transplant
22
Q
Dental Aspects of Cirrhosis
A
- bleeding problems
- drug contraindications
- viral transmission risk
- pre-procedure vitamin K
- pre-procedure transfuion
- hematology consult appropriate
- NO sedative, hypnotics
- N2O preferable to conscious sedation
- NO aspirin
- ONLY narrow-spectrum antibiotics
- increased risk of periotonitis with invasive dental procedures
23
Q
Symptoms of Hep B
A
- jaundice
- pruritus
- pale stool
- dark urine
- enlarged, tender liver
- myalgia
- arthralgia
24
Q
Infectious Hep
A
Hep A